Prevalence of obstructive sleep apnea in patients with prolactinoma before and after treatment with dopamine agonists
Conclusions
The OSA prevalence in patients with prolactinoma is similar to the obese subjects and did not change after treatment. Higher BMI and visceral obesity, but not prolactin levels, seem to be the major factor involved in the occurrence of OSA in these patients.
Source: Pituitary - Category: Endocrinology Source Type: research
More News: Cholesterol | Eating Disorders & Weight Management | Endocrinology | Insulin | Obesity | Obstructive Sleep Apnea | Sleep Apnea | Sleep Disorders | Sleep Medicine